News | Nov 30, 2006
Sales & Marketing agreement with InPheno
Epidauros enters into Sales & Marketing agreement with InPheno
Bernried, Germany / Basel, Switzerland - November 30, 2006 - Epidauros Biotechnologie AG, a leading pharmacogenetic research organization located in Bernried near Munich, and InPheno AG, a Basel (Swiss)-based provider of novel diagnostic methodologies in the areas of virology and oncology, jointly announce today that both companies entered into a mutually beneficial Sales & Marketing partnership.
Both partners intend to generate new business opportunities by jointly applying their unique skills and capabilities in the areas of genotyping and phenotyping with a particular focus on specific disease areas, such as virology and oncology.
Contact Epidauros
Dr. Michael Lutz
Chief Executive Officer
Phone: +49 (0)8158 9985 0
Fax: +49 (0)8158 9985 48
Email: contact@epidauros.com
File(s) | ||
 | Size: 183 K | |